Cargando…
Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals
OBJECTIVES: Patients with APS are at increased risk of thromboembolism. Neutrophils have been shown to play a role in inducing thrombosis. We aimed to investigate differences in neutrophil subpopulations, their potential of activation and neutrophil extracellular trap (NET) formation comparing high...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024003/ https://www.ncbi.nlm.nih.gov/pubmed/33026085 http://dx.doi.org/10.1093/rheumatology/keaa532 |
_version_ | 1783675221132181504 |
---|---|
author | Mauracher, Lisa-Marie Krall, Moritz Roiß, Johanna Hell, Lena Koder, Silvia Hofbauer, Thomas M Gebhart, Johanna Hayden, Hubert Brostjan, Christine Ay, Cihan Pabinger, Ingrid |
author_facet | Mauracher, Lisa-Marie Krall, Moritz Roiß, Johanna Hell, Lena Koder, Silvia Hofbauer, Thomas M Gebhart, Johanna Hayden, Hubert Brostjan, Christine Ay, Cihan Pabinger, Ingrid |
author_sort | Mauracher, Lisa-Marie |
collection | PubMed |
description | OBJECTIVES: Patients with APS are at increased risk of thromboembolism. Neutrophils have been shown to play a role in inducing thrombosis. We aimed to investigate differences in neutrophil subpopulations, their potential of activation and neutrophil extracellular trap (NET) formation comparing high and low-density neutrophils (HDNs/LDNs) as well as subpopulations in patients with APS and controls to gain deeper insight into their potential role in thrombotic manifestations in patients with APS. METHODS: HDNs and LDNs of 20 patients with APS and 20 healthy donors were isolated by density gradient centrifugation and stimulated. Neutrophil subpopulations, their activation and NET release were assessed by flow cytometry. RESULTS: LDNs of both groups showed higher baseline activation, lower response to stimulation (regulation of activation markers CD11b/CD66b), but higher NET formation compared with HDNs. In patients with APS, the absolute number of LDNs was higher compared with controls. HDNs of APS patients showed higher spontaneous activation [%CD11b high: median (interquartile range): 2.78% (0.58–10.24) vs 0.56% (0.19–1.37)] and response to stimulation with ionomycin compared with HDNs of healthy donors [%CD11b high: 98.20 (61.08–99.13) vs 35.50% (13.50–93.85)], whereas no difference was found in LDNs. NET formation was increased in patients’ HDNs upon stimulation. CONCLUSION: HDNs and LDNs act differently, unstimulated and upon various stimulations in both healthy controls and APS patients. Differences in HDNs and LDNs between patients with APS and healthy controls indicate that neutrophils may enhance the risk of thrombosis in these patients and could thus be a target for prevention of thrombosis in APS. |
format | Online Article Text |
id | pubmed-8024003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-80240032021-04-13 Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals Mauracher, Lisa-Marie Krall, Moritz Roiß, Johanna Hell, Lena Koder, Silvia Hofbauer, Thomas M Gebhart, Johanna Hayden, Hubert Brostjan, Christine Ay, Cihan Pabinger, Ingrid Rheumatology (Oxford) Clinical Science OBJECTIVES: Patients with APS are at increased risk of thromboembolism. Neutrophils have been shown to play a role in inducing thrombosis. We aimed to investigate differences in neutrophil subpopulations, their potential of activation and neutrophil extracellular trap (NET) formation comparing high and low-density neutrophils (HDNs/LDNs) as well as subpopulations in patients with APS and controls to gain deeper insight into their potential role in thrombotic manifestations in patients with APS. METHODS: HDNs and LDNs of 20 patients with APS and 20 healthy donors were isolated by density gradient centrifugation and stimulated. Neutrophil subpopulations, their activation and NET release were assessed by flow cytometry. RESULTS: LDNs of both groups showed higher baseline activation, lower response to stimulation (regulation of activation markers CD11b/CD66b), but higher NET formation compared with HDNs. In patients with APS, the absolute number of LDNs was higher compared with controls. HDNs of APS patients showed higher spontaneous activation [%CD11b high: median (interquartile range): 2.78% (0.58–10.24) vs 0.56% (0.19–1.37)] and response to stimulation with ionomycin compared with HDNs of healthy donors [%CD11b high: 98.20 (61.08–99.13) vs 35.50% (13.50–93.85)], whereas no difference was found in LDNs. NET formation was increased in patients’ HDNs upon stimulation. CONCLUSION: HDNs and LDNs act differently, unstimulated and upon various stimulations in both healthy controls and APS patients. Differences in HDNs and LDNs between patients with APS and healthy controls indicate that neutrophils may enhance the risk of thrombosis in these patients and could thus be a target for prevention of thrombosis in APS. Oxford University Press 2020-10-07 /pmc/articles/PMC8024003/ /pubmed/33026085 http://dx.doi.org/10.1093/rheumatology/keaa532 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Clinical Science Mauracher, Lisa-Marie Krall, Moritz Roiß, Johanna Hell, Lena Koder, Silvia Hofbauer, Thomas M Gebhart, Johanna Hayden, Hubert Brostjan, Christine Ay, Cihan Pabinger, Ingrid Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals |
title | Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals |
title_full | Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals |
title_fullStr | Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals |
title_full_unstemmed | Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals |
title_short | Neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals |
title_sort | neutrophil subpopulations and their activation potential in patients with antiphospholipid syndrome and healthy individuals |
topic | Clinical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024003/ https://www.ncbi.nlm.nih.gov/pubmed/33026085 http://dx.doi.org/10.1093/rheumatology/keaa532 |
work_keys_str_mv | AT mauracherlisamarie neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals AT krallmoritz neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals AT roißjohanna neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals AT helllena neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals AT kodersilvia neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals AT hofbauerthomasm neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals AT gebhartjohanna neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals AT haydenhubert neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals AT brostjanchristine neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals AT aycihan neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals AT pabingeringrid neutrophilsubpopulationsandtheiractivationpotentialinpatientswithantiphospholipidsyndromeandhealthyindividuals |